南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

整合型多组学研究揭示了肺腺癌中合成致死相关信号通路的预后及治疗价值

Integrative multi-omics reveals a prognostic and therapeutic landscape of synthetic lethality-associated signatures in lung adenocarcinoma

Zerong Li, Wenmei Qiao, Bin Fan, Fang Qiu, Wei Su

Journal:iScience

IF:4.5

DOI:10.1016/j.isci.2026.117098

PMID:42597961

Published:2026-08-03

research field:肿瘤学药理学药物化学有机合成药物发现

Abstract

Lung adenocarcinoma (LUAD) exhibits considerable heterogeneity and therapeutic resistance. Here, we integrated single-cell RNA sequencing, spatial transcriptomics, and machine learning to characterize synthetic lethality (SL)-associated transcriptional activity in LUAD. We quantified SL activity across malignant epithelial cells and stratified them into high-, dominant-, and low-SL groups. High-SL cells were enriched in advanced-stage and metastatic samples and showed reduced differentiation potential. Through multiple machine learning algorithms, we identified 13 high-SL signature genes, with IFRD2 (interferon-related developmental regulator 2) among the top contributors. Experimental validation confirmed IFRD2 upregulation in high-malignancy cell lines, and IFRD2 knockdown modulated sensitivity to the PARP inhibitor niraparib. The predicted compound prostaglandin A1 exhibited selective cytotoxicity against LUAD cells and induced DNA damage, consistent with an SL-related mechanism. Our findings establish a framework for identifying SL-associated vulnerabilities and provide a resource of candidate genes and compounds for further mechanistic investigation in LUAD precision therapy.

本文使用的Yeasen产品

购物车
客服
转染试用